Keranetics: Triad biotech company seeks $1.25M in funding

Regenerative medicine firm KeraNetics, which was spun out of research from the Wake Forest Institute for Regenerative Medicine, is seeking $1.25 million financing in a private offering, according to documents filed with the SEC. The Winston-Salem company plans to spend $275,000 of the $1.25 million to pay Kim Westmoreland, the company's CEO and managing director, according to the securities filing and a news story by the North Carolina Business News Wire, a service of UNC-Chapel Hill's School...